These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2177576)

  • 21. Structural analysis of the interaction between urokinase-type plasminogen activator and its receptor: a potential target for anti-invasive cancer therapy.
    Ploug M; Gårdsvoll H; Jørgensen TJ; Lønborg Hansen L; Danø K
    Biochem Soc Trans; 2002 Apr; 30(2):177-83. PubMed ID: 12023847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of human urokinase plasminogen activator in complex with its receptor.
    Huai Q; Mazar AP; Kuo A; Parry GC; Shaw DE; Callahan J; Li Y; Yuan C; Bian C; Chen L; Furie B; Furie BC; Cines DB; Huang M
    Science; 2006 Feb; 311(5761):656-9. PubMed ID: 16456079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasminogen receptors on rat colon carcinoma cells.
    Durliat M; Komano O; Correc P; Bertrand O; Cochet S; Caignard A; Martin F; Burtin P
    Br J Cancer; 1992 Jul; 66(1):51-6. PubMed ID: 1322156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urokinase-type plasminogen-activator receptor associates to a cell surface molecule in monocytic cells.
    Ragno P; Montuori N; Rossi G
    Biochem Biophys Res Commun; 1996 Jul; 224(1):252-7. PubMed ID: 8694822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor.
    Albo D; Rothman VL; Roberts DD; Tuszynski GP
    Br J Cancer; 2000 Aug; 83(3):298-306. PubMed ID: 10917542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulated localization confers multiple functions on the protease urokinase plasminogen activator.
    Wells JM; Strickland S
    J Cell Physiol; 1997 May; 171(2):217-25. PubMed ID: 9130470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.
    Yin S; Lockett J; Meng Y; Biliran H; Blouse GE; Li X; Reddy N; Zhao Z; Lin X; Anagli J; Cher ML; Sheng S
    Cancer Res; 2006 Apr; 66(8):4173-81. PubMed ID: 16618739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferons and retinoids enhance and dexamethasone suppresses urokinase-mediated plasminogen activation in promyelocytic leukemia cells.
    Mustjoki S; Tapiovaara H; Sirén V; Vaheri A
    Leukemia; 1998 Feb; 12(2):164-74. PubMed ID: 9519778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
    McGowen R; Biliran H; Sager R; Sheng S
    Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular receptor for urokinase-type plasminogen activator: protein structure.
    Behrendt N; Ploug M; Rønne E; Høyer-Hansen G; Danø K
    Methods Enzymol; 1993; 223():207-22. PubMed ID: 8271954
    [No Abstract]   [Full Text] [Related]  

  • 31. Cryptic urokinase binding sites on human foreskin fibroblasts.
    Bajpai A; Baker JB
    Biochem Biophys Res Commun; 1985 Dec; 133(2):475-82. PubMed ID: 3002345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urokinase-type plasminogen activator and its receptor in bladder cancer.
    Hasui Y; Osada Y
    J Natl Cancer Inst; 1997 May; 89(10):678-9. PubMed ID: 9168177
    [No Abstract]   [Full Text] [Related]  

  • 33. Cell membrane receptors for urokinase plasminogen activator are increased in malignant ovarian tumours.
    Casslén B; Gustavsson B; Astedt B
    Eur J Cancer; 1991; 27(11):1445-8. PubMed ID: 1660294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes are not internalized upon binding to the urokinase-type-plasminogen-activator receptor in THP-1 cells. Interaction of urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes with the cell surface.
    Ragno P; Montuori N; Rossi G
    Eur J Biochem; 1995 Oct; 233(2):514-9. PubMed ID: 7588796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Yeast expression and phagemid display of the human urokinase plasminogen activator epidermal growth factor-like domain.
    Stratton-Thomas JR; Min HY; Kaufman SE; Chiu CY; Mullenbach GT; Rosenberg S
    Protein Eng; 1995 May; 8(5):463-70. PubMed ID: 8532668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasminogen activation by receptor-bound urokinase.
    Ellis V; Danø K
    Semin Thromb Hemost; 1991 Jul; 17(3):194-200. PubMed ID: 1665584
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of hormones on uPA, PAI-1 and suPAR from cultured endometrial and ovarian endometriotic stromal cells.
    Guan YM; Carlberg M; Bruse C; Carlström K; Bergqvist A
    Acta Obstet Gynecol Scand; 2002 May; 81(5):389-97. PubMed ID: 12027810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor.
    Cubellis MV; Andreasen P; Ragno P; Mayer M; Danø K; Blasi F
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):4828-32. PubMed ID: 2544876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction.
    Høyer-Hansen G; Behrendt N; Ploug M; Danø K; Preissner KT
    FEBS Lett; 1997 Dec; 420(1):79-85. PubMed ID: 9450554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.
    Falcone DJ; McCaffrey TA; Mathew J; McAdam K; Borth W
    J Cell Physiol; 1995 Aug; 164(2):334-43. PubMed ID: 7622580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.